Camille Tumiotto

Centre National de la Recherche Scientifique — France

Immunology and Microbiology · Life Sciences

13h-index776citations46works8.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(23), HIV/AIDS drug development and treatment(19), HIV/AIDS Research and Interventions(13), SARS-CoV-2 and COVID-19 Research(6), vaccines and immunoinformatics approaches(6)

Publications40 total

First characterization of insertions in the HIV-1 integrase-coding region from people with HIV
Journal of Antimicrobial Chemotherapy·2025
Comparison of methods to quantify inducible HIV-1 outgrowth
UNC Libraries·2025Open Access
Molecular basis for the regulation of retroviral nucleosomal integration by chromatin compaction
2025Open Access
Room temperature storage and shipping of encapsulated synthetic RNAs as quality control materials for SARS-CoV-2 molecular diagnostic assays
Journal of Virological Methods·2025· 1 cited
A case of lenacapavir use for preventing mother-to-child HIV transmission
Journal of Antimicrobial Chemotherapy·2024· 5 citedOpen Access
Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study
Scientific Reports·2023· 12 citedOpen Access
Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017
Nephrology Dialysis Transplantation·2023· 10 cited
Reference materials for SARS-CoV-2 molecular diagnostic quality control: validation of encapsulated synthetic RNAs for room temperature storage and shipping
2023· 1 citedOpen Access
Modulation of the functional interfaces between retroviral intasomes and the human nucleosome
mBio·2023· 3 citedOpen Access
Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis
AIDS·2023· 28 cited
Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007–2018
International Journal of Antimicrobial Agents·2022· 3 cited
Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study
The Lancet Infectious Diseases·2022· 163 citedOpen Access
Modulation of the functional interfaces between retroviral intasomes and the human nucleosome
2022· 2 citedOpen Access
Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France
Journal of Clinical Virology·2022· 2 citedOpen Access
Modulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF/p75
Nucleic Acids Research·2021· 18 citedOpen Access
A Simple and Fast Method to Sequence the Full-Length Spike Gene for SARS-CoV-2 Variant Identification from Patient Samples
COVID·2021· 9 citedOpen Access
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey
Journal of Antimicrobial Chemotherapy·2021· 13 citedOpen Access
Comparison of methods to quantify inducible HIV-1 outgrowth
Journal of Virus Eradication·2021· 11 citedOpen Access
Feasibility of convalescent plasma therapy in severe COVID‐19 patients with persistent SARS‐CoV‐2 viremia
Journal of Medical Virology·2021· 5 citedOpen Access
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR cycle amplification values
2021· 9 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Pantxika Bellecave(14), Fabrice Bonnet(9), Marie‐Edith Lafon(8), Patrícia Recordon-Pinson(7), Laurence Bocket(6), Brigitte Montès(6), Anne Signori-Schmück(6), Magali Bouvier‐Alias(6), Hervé Fleury(6), John W. Mellors(5), Corinne Amiel(5), Laurence Morand‐Joubert(5), Catherine Roussel(5), Vincent Cálvez(5), Benoît Visseaux(5), Virginie Ferré(5), Anne De Monte(5), Sophie Vallet(5), Delphine Lapaillerie(5), Vincent Parissi(5)